Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Yourgene to process tests at lab as part of MyHealthChecked Boots deal

Mon, 22nd May 2023 14:26

(Alliance News) - Yourgene Health PLC on Monday said that is due to process diagnostic tests at its laboratory in Manchester, as part of a deal signed by its partner, MyHealthChecked PLC, with Boots UK Ltd.

Yourgene is a Manchester, England-based molecular diagnostic group, while MyHealthChecked is a consumer home-testing healthcare company.

Last Friday, MyHealthChecked PLC said it had signed an agreement via its subsidiary, Concepta Diagnostics Ltd, to launch its extended range of products with Boots UK.

Yourgene told investors on Monday that, according to the service agreement, five out of the 14 tests that MyHealthChecked are launching via Boots will be processed by Yourgene Genomic Services at its accredited laboratory in Manchester.

"We would like to congratulate our partner MyHealthChecked on their retail launch with Boots of their extended product portfolio, which demonstrates execution of the next step of their strategic plan. Yourgene is proud to continue to support MyHealthChecked with our state-of-the-art laboratory and the contract is a testament to the quality of the service we provide," said Chief Executive Office Lyn Rees.

Separately, Yourgene said it has reappointed Chief Scientific Officer Joanne Mason as a director of the company with immediate effect.

"Given Dr Mason's background and experience in this field, she is playing an increasingly pivotal role for the company in highlighting the technical benefits of the company's offerings to potential and existing customers, and her expertise provides an important complement to the skills and understanding of the wider board," Yourgene said.

Yourgene shares were trading 1.8% higher at 0.21 pence each in London on Monday afternoon.

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 Jul 2019 10:07

Yourgene Health Swings To Profit After Debt Write-Off, Strong Trading

(Alliance News) - Yourgene Health PLC on Wednesday posted a swing to profit for its recent financial year due to improved trading and substantial gains on debt restructuring.Shares in were

Read more
3 Jun 2019 16:04

DIRECTOR DEALINGS: Yourgene Health Non-Exec Chair Reynolds Buys Shares

LONDON (Alliance News) - Yourgene Health PLC on Monday said Non-Executive Chair Adam Reynolds bought shares in the diagnostic products developer in a transaction on Friday last purchased 900,000 a

Read more
3 Jun 2019 15:26

Director dealings: Yourgene chairman raises stake

(Sharecast News) - Yourgene Health revealed on Monday that chairman Adam Reynolds had acquired 900,000 ordinary shares in the AIM-listed molecular diagnostics outfit.

Read more
9 May 2019 17:32

DIRECTOR DEALINGS: Yourgene Finance And Operating Chiefs Buy Shares

LONDON (Alliance News) - Yourgene Health PLC said on Thursday that Chief Financial Officer Barry Hextall and Chief Operating Officer Hayden Jeffreys have purchased around GBP35,800 in stock them

Read more
17 Apr 2019 17:29

Yourgene Health Fundraises To Buy Delta Diagnostics For GBP9 Million (ALLISS)

LONDON (Alliance News) - Yourgene Health PLC on Wednesday proposed an acquisition of Delta Diagnostics UK Ltd for an enterprise value of GBP8.8 million.The diagnostic products developer of

Read more
8 Apr 2019 11:37

Yourgene revenues beat estimates on solid international performance

(Sharecast News) - Molecular diagnostics group Yourgene saw annual revenues exceed market expectations in its 2018 trading year, driven by a strong performance from its international arm.

Read more
8 Apr 2019 09:13

International Performance Leads Revenue Rise For Yourgene Health

LONDON (Alliance News) - Yourgene Health PLC on Monday said its annual revenue was ahead of market expectations, with international revenue particularly strong.Shares in molecular company a

Read more
8 Jan 2019 14:22

Yourgene Health launches Sage 32 plex test

(Sharecast News) - Molecular diagnostics group Yourgene Health announced the launch of the 'Sage 32' plex test - a high throughput non-invasive prenatal testing (NIPT) and analysis solution for clinical laboratories - on Tuesday.

Read more
8 Jan 2019 10:07

Yourgene Health Launches Sage 32 Plex Test For Clinical Laboratories

LONDON (Alliance News) - Yourgene Health PLC on Tuesday said it launched the Sage 32 plex test, a new high-throughput, non-invasive prenatal testing and analysis solution for clinical molecular 32

Read more
3 Dec 2018 12:01

Yourgene Health Interim Loss Narrows On Double-Digit Revenue Growth

LONDON (Alliance News) - Yourgene Health PLC on Monday said its loss narrowed in the first half of its current financial year as revenue rose on improved non-invasive prenatal testing products its

Read more
3 Dec 2018 10:27

Yourgene Health international expansion sees revenue jump 45%

(Sharecast News) - Yourgene Health's shares dropped on Monday as the company returned a loss even after interim revenue increased by almost 50%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.